SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-073140
Filing Date
2012-11-01
Accepted
2012-11-01 14:49:27
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20102_110q.htm 10-Q 977286
2 EX-10.1 a12-20102_1ex10d1.htm EX-10.1 62922
3 EX-31.1 a12-20102_1ex31d1.htm EX-31.1 11476
4 EX-31.2 a12-20102_1ex31d2.htm EX-31.2 11329
5 EX-32.1 a12-20102_1ex32d1.htm EX-32.1 4280
6 EX-32.2 a12-20102_1ex32d2.htm EX-32.2 4272
13 GRAPHIC g201021kei001.jpg GRAPHIC 4415
  Complete submission text file 0001104659-12-073140.txt   7198082

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pcrx-20120930.xml EX-101.INS 1053496
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20120930.xsd EX-101.SCH 51225
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20120930_cal.xml EX-101.CAL 66819
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT pcrx-20120930_lab.xml EX-101.LAB 799014
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20120930_pre.xml EX-101.PRE 365925
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20120930_def.xml EX-101.DEF 267245
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 121173150
SIC: 2834 Pharmaceutical Preparations